FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000GG2QWX3

Real-time BOERSE MUENCHEN 02:26:53 2024-06-21 pm EDT
13.79 EUR -8.43% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP.
Current month+0.87%
1 month+27.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-21 13.79 -8.43%
24-06-20 15.06 -27.21%
24-06-19 20.69 +10.64%
24-06-18 18.7 +10.19%
24-06-17 16.97 +6.06%

Real-time BOERSE MUENCHEN

Last update June 21, 2024 at 02:26 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GG2QWX
ISINDE000GG2QWX3
Date issued 2024-01-18
Strike 315.1 $
Maturity Unlimited
Parity 1.77 : 1
Emission price 21.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 73.66
Lowest since issue 9.58
Spread 0.2
Spread %1.43%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.4 USD
Average target price
372.9 USD
Spread / Average Target
+9.25%
Consensus